About GCP Research

Empowering You with Knowledge

If you're new to clinical studies and wish to understand more about the process, benefits, and what to expect, please visit our About Clinical Studies page. We provide comprehensive information to help you make informed decisions about your participation.​

About GCP Research

Our Mission

At GCP Research, we are dedicated to ensuring the highest standards of safety and comfort for all volunteers participating in our clinical trials. Our experienced medical team is committed to delivering exceptional care and contributing to the advancement of medical treatments that will benefit society for generations

What We Do

GCP Research specializes in conducting Phase 2 and Phase 3 clinical trials.

  • Phase 2 trials evaluate the safety and efficacy of investigational drugs.
  • Phase 3 trials compare investigational treatments to current standard therapies to determine their effectiveness.

Clinical trials are a vital step in the development of all modern medications. No new treatment can be approved without first successfully completing this rigorous process.

Participant Safety and Consent

The safety and well-being of our study participants is our top priority. All volunteers undergo a thorough informed consent process, during which they are made fully aware of all procedures, potential risks, and their rights. Participation is entirely voluntary, and individuals are free to withdraw at any time.

24-Hour Clinical Capabilities for Overnight Studies

At Montreal Clinical Trials, we are fully equipped to conduct studies requiring overnight stays with around-the-clock medical oversight. Our 24-hour capabilities ensure participant safety, comfort, and continuous data collection in a controlled, professional environment. Whether for Phase I trials or intensive monitoring protocols, our facility is designed to meet the highest standards in clinical research.​

Our facility is accredited by Accreditation Canada, reflecting our commitment to excellence in patient care and adherence to rigorous national standards. The center offers state-of-the-art technology and a highly secure environment, featuring three operating rooms, a procedure room, and dedicated spaces for patient preparation and recovery.

Their team of health professionals is hand-picked for their skills and commitment, ensuring a dynamic and compassionate approach to patient care. ​
Together, we provide a comprehensive solution for clinical studies requiring overnight stays, combining advanced medical infrastructure with a patient-centered approach.

Our Location

Our primary facility is in the located at 3232 Bélanger Est #403, Montreal, Quebec H1Y 1B7, where all Phase 2, Phase 3, and overnight studies are conducted.

Study Experience

Type of Clinical Trial

# of Studies

Diabetes Mellitus

14

Bronchitis

7

Emphysema

6

Asthma

6

Cardiac Ischemia

5

Anxiety Disorder

3

Atherosclerosis

3

Duodenal Ulcer

3

Hyperlipidemia

3

Mood disorders

3

Type of Clinical Trial

# of Studies

Alzheimer’s

3

Osteoarthritis

3

Sexual Disorders

3

Esophageal Disorders

2

Psoriasis

2

Allergic Disorders

1

Cerebral Ischemia

1

Coagulation Defects

1

Peripheral Vascular Disease

1

Rheumatoid Arthritis

1

Our Facilities

State-of-the-Art Research Environments

State of the Art Patient Rooms

GCP Research - Patient Accomodations

Modern Design

GCP Research - Main Entrance

Professional & Elegant Setting

GCP Research - Clinical Entrance

Top Quality Patient Amenities

GCP Research - Main Entrance #2

Book an appmountment

Join today to be added to our list of candidates for upcoming studies.

All participants are compensated and information is 100% confidential.

Present Studies

Now Enrolling – Find a Study That Fits You

Hot Flashes Breast Cancer

You must have the following criteria to participate in the study on hot flashes and breast cancer:

COPD

COPD / Smokers Study: You must have the following criteria to participate in the study on COPD:

Chronic Cough

Chronic Cough Study: Must have the following criteria to participate in the study on Chronic Cough: